Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Im Cannabis Corp (IMCC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: IMCC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.22
1 Year Target Price $8.22
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 25.95% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.93M USD | Price to earnings Ratio - | 1Y Target Price 8.22 |
Price to earnings Ratio - | 1Y Target Price 8.22 | ||
Volume (30-day avg) 1 | Beta 2.02 | 52 Weeks Range 1.20 - 7.12 | Updated Date 11/6/2025 |
52 Weeks Range 1.20 - 7.12 | Updated Date 11/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.48 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.75% | Operating Margin (TTM) -2.76% |
Management Effectiveness
Return on Assets (TTM) -7.17% | Return on Equity (TTM) -48.5% |
Valuation
Trailing PE - | Forward PE 16.31 | Enterprise Value 20742567 | Price to Sales(TTM) 0.13 |
Enterprise Value 20742567 | Price to Sales(TTM) 0.13 | ||
Enterprise Value to Revenue 0.55 | Enterprise Value to EBITDA 7.3 | Shares Outstanding 5246812 | Shares Floating 2183309 |
Shares Outstanding 5246812 | Shares Floating 2183309 | ||
Percent Insiders 44.66 | Percent Institutions 4.58 |
Upturn AI SWOT
Im Cannabis Corp
Company Overview
History and Background
Im Cannabis Corp is a global cannabis company with operations in Israel, Canada, and Europe. The company was founded to leverage Israel's expertise in cannabis research and development and has since expanded into international markets.
Core Business Areas
- Medical Cannabis: Cultivation, processing, and distribution of medical cannabis products for patients with qualifying conditions. Includes various strains, oils, and other formulations.
- Recreational Cannabis (Canada): Cultivation, processing, and distribution of recreational cannabis products for adult consumers in Canada.
- Pharmaceutical Development: Research and development of cannabis-based pharmaceutical products for specific medical conditions.
- Distribution & Retail: Sale of cannabis products direct to consumer and wholesale distribution through other retailers.
Leadership and Structure
The leadership team consists of experienced executives in the cannabis, pharmaceutical, and consumer goods industries. The organizational structure is divided into functional departments, including cultivation, processing, sales and marketing, and research and development.
Top Products and Market Share
Key Offerings
- Medical Cannabis Oils: Various medical cannabis oil formulations targeting specific conditions like pain, anxiety, and insomnia. Market share data unavailable due to fragmented market. Competitors include Tilray, Canopy Growth, and Aurora Cannabis in the medical market.
- Dried Flower: Cultivation and sale of dried cannabis flower for both medical and recreational use. Market share data unavailable due to fragmented market. Competitors include OrganiGram, Cronos Group, and Village Farms International.
- Cannabis Extracts & Concentrates: Production and distribution of cannabis extracts and concentrates such as shatter, wax, and vape cartridges. Market share data unavailable due to fragmented market. Competitors include Valens Company and Neptune Wellness Solutions.
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth driven by increasing legalization and acceptance of cannabis for medical and recreational use. The market is highly competitive and subject to evolving regulations.
Positioning
Im Cannabis Corp positions itself as a global leader in the cannabis industry, leveraging its expertise in cannabis research and development and its international presence. It aims to differentiate itself through high-quality products and a focus on innovation.
Total Addressable Market (TAM)
The global cannabis market is expected to reach hundreds of billions of dollars in the next decade. Im Cannabis Corp is positioned to capture a portion of this market through its operations in Israel, Canada, and Europe. The TAM is estimated to be around $200 Billion USD.
Upturn SWOT Analysis
Strengths
- International presence
- Strong research and development capabilities
- Focus on high-quality products
- Expertise in medical cannabis
Weaknesses
- Limited brand recognition compared to larger competitors
- Reliance on regulatory changes
- Currently unprofitable
- Small market share
Opportunities
- Expansion into new markets
- Development of innovative cannabis-based products
- Partnerships with pharmaceutical companies
- Increased legalization of cannabis
Threats
- Intense competition
- Changing regulations
- Fluctuations in cannabis prices
- Negative public perception of cannabis
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- ACB
- CRON
- VFF
- OGI
Competitive Landscape
Im Cannabis Corp faces intense competition from larger and more established companies. The company must differentiate itself through high-quality products, innovation, and a strong brand identity.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data unavailable.
Future Projections: Future growth projections are uncertain due to the evolving nature of the cannabis industry.
Recent Initiatives: Recent initiatives include expansion into new markets, development of new products, and partnerships with other companies.
Summary
Im Cannabis Corp is a global cannabis company that operates in a rapidly growing and competitive market. While it has strengths in international presence and research, it faces challenges from larger competitors and regulatory uncertainties. The company's future success depends on its ability to innovate, expand into new markets, and establish a strong brand identity.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company reports
- Industry analysis reports
- Market research data
Disclaimers:
The data and analysis provided are based on publicly available information and are subject to change. This is not financial advice, and investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Im Cannabis Corp
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2020-05-20 | CEO & Executive Director Mr. Oren Shuster | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees - | Website https://imcannabis.com |
Full time employees - | Website https://imcannabis.com | ||
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.